¼¼°èÀÇ Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå : À¯Çüº°, Á¦Ç°º°, Áúȯº°, ±â¼úº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Adipose Derived Stem Cell Market, By Type, By Product Type, By Disease, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1464679
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 279 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,503,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,443,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,829,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ Áö¹æ À¯·¡ Áٱ⼼Æ÷(ADSC, Adipose Derived Stem Cell) ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 21¾ï 4,450¸¸ ´Þ·¯¿¡ ´ÞÇßÀ¸¸ç, 2024-2032³â¿¡ °ÉÃÄ CAGR 14.5%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå-½ÃÀå ¿ªÇÐ

ÃÖ¼Ò Ä§½À ¹Ì¿ë ¼ºÇü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹Ãø

Áö¹æ ÈíÀÔÀº ADSC ºÐ¸®¸¦ À§ÇØ Áö¹æ Á¶Á÷À» äÃëÇÏ´Â µ¥ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â ÀýÂ÷À̸ç ADSC ±â¹Ý Ä¡·á¸¦À§ÇÑ Áö¹æ Á¶Á÷ÀÇ °¡¿ë¼º¿¡ ±â¿©ÇÕ´Ï´Ù. ¹Ì±¹Çü¼º¿Ü°úÇÐȸ(ASPS)´Â 2018³â ¹Ì±¹¿¡¼­ ¾à 1,800¸¸ ¸íÀÌ ¼ö¼úÀûÀ̰í ħ½ÀÀûÀÎ ¹Ì¿ë ¼ºÇü ¼ö¼úÀ» ¹Þ¾Ò´Ù°í º¸°íÇßÀ¸¸ç, Áõ°¡ Ãß¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀåÀÇ ¼ºÀåÀº ADSC¸¦ ±â¹ÝÀ¸·Î ÇÏ´Â Á¦Ç°°ú Ä¡·á¹ýÀ» »ó¿ëÈ­ÇÏ´Â ±â¾÷µé¿¡°Ôµµ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á°¡ ½ÃÀå È®´ë¿¡ Á¦¾àÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ´Ù´Â Á¡¿¡ ÁÖÀÇÇØ¾ß ÇÕ´Ï´Ù.

Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå-ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â)¿¡ CAGR ¾à 14.5%·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

À¯Çüº°·Î, µ¿Á¾ Áٱ⼼Æ÷´Â 2023³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¸ÅÃâÀ» À̲ø°í ÀÖ½À´Ï´Ù.

Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå-¼¼ºÐÈ­ ºÐ¼® :

¼¼°èÀÇ Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀåÀº À¯Çü, Á¦Ç°, Áúº´, ±â¼ú, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº À¯Çü¿¡ µû¶ó µÎ ±×·ìÀ¸·Î ºÐ·ùµË´Ï´Ù. Áï, ÀÚ°¡ Áٱ⠼¼Æ÷¿Í µ¿Á¾ Áٱ⠼¼Æ÷ÀÔ´Ï´Ù. µ¿Á¾ Áٱ⠼¼Æ÷°¡ ½ÃÀåÀÇ ´ëºÎºÐÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. Áö¹æÀ¯·¡ Áٱ⼼Æ÷¿Í µ¿Á¾ Áٱ⠼¼Æ÷ÀÇ Á¶ÇÕÀº Àç»ý ÀÇÇп¡¼­ Áß¿äÇÑ ¿¬±¸ ºÐ¾ßÀ̸ç Áøº¸ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Áٱ⼼Æ÷°ø±Þ¿øÀº ¸íÈ®ÇÑ ÀÌÁ¡À» Á¦°øÇϰí ÀÖÀ¸¸ç, ´Ù¾çÇÑ Áúº´À̳ª º´¸®ÇÐÀÇ Ä¡·á °¡´É¼º¿¡ ´ëÇØ ÇöÀç ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀåÀº Á¦Ç°¿¡ µû¶ó 4°³ÀÇ ±×·ìÀ¸·Î ±¸ºÐµË´Ï´Ù : ¼¼Æ÷ÁÖ, ¹è¾ç¾×, ¹èÁö, Ç÷û, ½Ã¾à. Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå¿¡´Â ¼¼Æ÷ÁÖ, ¹è¾ç¾×, ¹èÁö, Ç÷û, ½Ã¾à µî Æø³ÐÀº Á¦Ç°ÀÌ Æ÷ÇԵǾî ÀÖÀ¸¸ç, ÀÌµé ¸ðµÎ Àç»ýÀÇ·á ºÐ¾ß¿¡¼­ÀÇ ¿¬±¸°³¹ß ¹× »ó¾÷È­ÀÇ ÃßÁø¿¡ ÇʼöÀûÀÔ´Ï´Ù.

½ÃÀåÀº Áúº´º°·Î 8°¡Áö Ä«Å×°í¸®·Î ºÐ·ùµÇ¾î ÀÖ½À´Ï´Ù : ¾Ï, ºñ¸¸, »ó󡤻óÇØ, ±Ù°ñ°Ý°è Áúȯ, ½ÉÀåÇ÷°ü°è Áúȯ, ÁßÃ߽Űæ°è Áúȯ, ´ë»ç¼º Áúȯ, ¼ÒÈ­±â°è Áúȯ, ±âŸ Áúȯ. Áö¹æ À¯·¡ Áٱ⼼Æ÷´Â ¹ü¿ë¼ºÀÌ ³ô°í Àç»ý´É·ÂÀ» °¡Áö±â ¶§¹®¿¡ Æø³ÐÀº ÀÇ·á ºÐ¾ß¿¡¼­ Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÇ À¯¸ÁÇÑ È帷ΠÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ÃÖÁ¾ »ç¿ëÀÚº°·Î ¼¼Æ÷ ÀºÇà, Á¶Á÷ ÀºÇà, ¿¬±¸¼Ò, Çмú ±â°ü, º´¿ø, ¿Ü»ó ¼¾ÅÍ µîÀ¸·Î ºÐ·ùµË´Ï´Ù. Àç»ý ÀÇ·á ºÐ¾ßÀÇ Áøº¸¸¦ ÃËÁøÇϰí ADSC ±â¹Ý Ä¡·á¹ýÀÇ ÀÓ»ó ÀÀ¿ëÀ» ÃËÁøÇϱâ À§Çؼ­´Â ÀÌ·¯ÇÑ ÀÌÇØ °ü°èÀÚÀÇ Çù·Â°ú ÇÐÁ¦ °£ ³ë·ÂÀÌ ÇʼöÀûÀÔ´Ï´Ù.

Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå-Áö¸®Àû ÅëÂû

Áö¿ªÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ³²¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ³Î¸® ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº »ç¾÷ Ȱµ¿À» ÇÏ´Â ±¹°¡¿¡ µû¶ó ´õ ºÐ·ùµË´Ï´Ù. ½ÃÀåÀº ÁÖ·Î ºÏ¹Ì°¡ Áö¹èÀûÀÌÁö¸¸, ÀÌ´Â ÁÖ·Î ´Ù¾çÇÑ Á¶Á÷¿¡ ÀÇÇÑ ¿¬±¸°³¹ß ÀÌ´Ï¼ÅÆ¼ºêÀÇ ¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ƯÈ÷ ¹Ì±¹ ±¹¸³À§»ý¿¬±¸¼Ò(NIH)¿Í °°Àº ºÏ¹Ì Á¤ºÎ ±â°üÀº Áٱ⼼Æ÷ ¿¬±¸¿¡ ¾öû³­ ÀÚ±ÝÀ» Á¦°øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ ÀçÁ¤ Áö¿øÀº ¿¬±¸ °³¹ß ³ë·ÂÀ» Å©°Ô °¡¼ÓÈ­ÇÏ°í ±â¼ú Çõ½ÅÀ» ÃËÁøÇϸç ADSCÀÇ »ý¹°ÇÐÀû ÀÌÇØ¿Í Ä¡·á ÀÀ¿ëÀÇ ¹ßÀü¿¡ ±â¿©ÇÕ´Ï´Ù. 2019³â ¹Ì±¹Àº ¿¬±¸°³¹ß(R&D)ÀÇ ´«ºÎ½Å ½ÇÀûÀ» ¸ñ°ÝÇÏ¿© 6,670¾ï ´Þ·¯¿¡ ´ÞÇßÁö¸¸, Àü¹Ì°úÇÐÀç´ÜÀÇ º¸°í¿¡ µû¸£¸é 2020³â¿¡´Â ´õ¿í Áõ°¡ÇØ 7,080¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤ µÇ¾ú½À´Ï´Ù. À¯·´Àº ÁÖ·Î Àç»ýÀÇ·á¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀå¿¡¼­ 2À§¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå-°æÀï ±¸µµ :

Áö¹æÀ¯·¡ Áٱ⼼Æ÷(ADSC) ½ÃÀå °æÀï ±¸µµÀº ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼­ ADSCÀÇ Ä¡·á È¿°ú¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡¿¡ ÀÇÇØ Çü¼ºµË´Ï´Ù. °¢ ±â¾÷Àº ¿¬±¸ ¹× ÀÓ»ó ºÐ¾ß¿¡¼­ ADSC¸¦ ºÐ¸®, È®Àå ¹× ÀÀ¿ëÇÒ ¼ö ÀÖ´Â µ¶ÀÚÀûÀÎ Á¦Ç°°ú ±â¼úÀ» °³¹ßÇÏ¿© Ÿ»ç¿Í Â÷º°È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ »õ·Î¿î Áö¿ª¿¡ ÁøÃâÇϰųª ÆÇ¸Å¾÷ü¿Í Á¦ÈÞÇϰí, Àç»ý ¹Ì¿ë°ú ¼öÀÇÇÐ µî ½ÅÈï ºÐ¾ß¿¡ ÁÖ·ÂÇÔÀ¸·Î½á ADSC ½ÃÀå¿¡¼­ÀÇ µµ´Þ¹üÀ§¸¦ ³ÐÈ÷·Á Çϰí ÀÖ½À´Ï´Ù. ½ÃÀå È®´ë Àü·«À¸·Î´Â ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ Ãëµæ, ½ÃÀå ÁøÀÔ ÀÌ´Ï¼ÅÆ¼ºêÀÇ °³½Ã, Çコ ÄÉ¾î »ê¾÷ÀÇ À¯·ÂÀÚ¿Í Àü·«Àû ÆÄÆ®³Ê½Ê Çü¼º µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Áö¹æÀ¯·¡ Áٱ⼼Æ÷ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Áö¹æÀ¯·¡ Áٱ⼼Æ÷ÀÇ »ê¾÷ ¿¬±¸

Á¦5Àå Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå : COVID-19 ¿µÇ⠺м®

Á¦6Àå Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå »óȲ

Á¦7Àå Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå-À¯Çüº°

Á¦8Àå Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå-Á¦Ç°º°

Á¦9Àå Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå-Áúȯº°

Á¦10Àå Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå-ÃÖÁ¾ »ç¿ëÀÚº°

Á¦11Àå Áö¹æÀ¯·¡ Áٱ⼼Æ÷ ½ÃÀå-Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼®-Áö¹æÀ¯·¡ Áٱ⼼Æ÷ »ê¾÷

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LYJ
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Adipose Derived Stem Cell Market size was valued at USD 2,144.5 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

Adipose-derived stem cells (ADSCs) possess the ability to sustain self-renewal and exhibit an enhanced potential for multiple types of differentiation. This is achieved through the secretion of diverse paracrine factors and extracellular vesicles, enabling them to effectively restore impaired organs and tissues. As a result, there has been a growing focus on utilizing ADSCs in the fields of tissue engineering and organ regeneration. Obtaining ADSCs in substantial quantities is relatively straightforward, as they can be acquired through minimally invasive techniques like liposuction. This accessibility renders them an appealing source for applications in regenerative medicine and tissue engineering. Extensive research has been conducted to explore their therapeutic potential in addressing various medical conditions, including tissue repair, wound healing, and the regeneration of damaged or diseased tissues.

Adipose Derived Stem Cell Market- Market Dynamics

Rising demand for minimally invasive cosmetic procedures is anticipated to fuel market growth

Liposuction, which is a commonly used procedure for harvesting adipose tissue for ADSC isolation, is contributing to the availability of adipose tissue for ADSC-based therapies. The American Society of Plastic Surgeons (ASPS) reported that nearly 18 million individuals underwent surgical and minimally invasive cosmetic procedures in the United States in 2018, indicating a rising trend. This growth in the market is also creating opportunities for companies to commercialize ADSC-based products and therapies. However, it is important to note that safety concerns may pose restrictions on the market's expansion.

Adipose Derived Stem Cell Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on Type segmentation, Allogeneic Stem Cells were predicted to show maximum market share in the year 2023

Based on region, North America was the leading revenue generator in 2023

Adipose Derived Stem Cell Market- Segmentation Analysis:

The Global Adipose Derived Stem Cell Market is segmented based on Type, Product Type, Disease, Technology and Region.

The market is categorized into two groups according to Type: Autologous Stem Cells and Allogeneic Stem Cells. Allogeneic Stem Cells hold the majority share in the market. The combination of adipose-derived stem cells and allogeneic stem cells is a significant field of study and advancement in regenerative medicine. These sources of stem cells provide distinct benefits and are currently under investigation for their potential in treating various diseases and medical conditions.

The market is segmented into four groups according to Product Type: Cell line, Culture media, Media, Sera, and Reagents. The market for adipose-derived stem cells includes a wide range of products, such as cell lines, culture media, sera, and reagents, all of which are essential for driving progress in research, development, and commercialization within the regenerative medicine sector.

The market is segmented into eight categories according to Disease: Cancer, Obesity, Wounds and Injuries, Musculoskeletal Diseases, Cardiovascular Diseases, Central Nervous System Diseases, Metabolic Diseases, Gastro-intestinal Diseases, and Other conditions. Adipose-derived stem cells are highly versatile and possess regenerative capabilities, positioning them as promising candidates for innovative therapies in a wide range of medical fields.

The market is categorized into three groups based on End-User: Cell banks & tissue banks, Research laboratories and Academic institutes, Hospitals and Trauma centers and Others. It is imperative for collaboration and interdisciplinary efforts among these stakeholders to drive advancements in the field of regenerative medicine and facilitate the translation of ADSC-based therapies into clinical practice.

Adipose Derived Stem Cell Market- Geographical Insights

Geographically, this market is extensively spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries involved in business activities. The market is predominantly dominated by North America, primarily due to the growing number of research and development initiatives undertaken by various organizations. Notably, government agencies in North America, such as the National Institutes of Health (NIH) in the U.S., play a significant role by providing substantial funding for stem cell research. This financial support greatly accelerates research and development efforts, fosters innovation, and contributes to advancements in understanding ADSC biology and therapeutic applications. In 2019, the United States witnessed a remarkable research and experimental development (R&D) performance, reaching USD 667 billion, and it is estimated to have further increased to USD 708 billion in 2020, as reported by the National Science Foundation. Europe holds the second-largest region for market growth, primarily driven by the increasing consumer awareness of regenerative medicine.

Adipose Derived Stem Cell Market- Competitive Landscape:

The competitive landscape of the market for adipose-derived stem cells (ADSC) is shaped by the growing awareness of the therapeutic benefits of ADSCs in different medical fields. Businesses aim to set themselves apart by creating unique products and technologies for the isolation, expansion, and application of ADSCs in both research and clinical settings. They are also looking to broaden their reach in the ADSC market by venturing into new regions, forming partnerships with distributors, and focusing on emerging areas like regenerative aesthetics and veterinary medicine. Strategies for market expansion may involve obtaining regulatory approvals, launching market access initiatives, and forming strategic partnerships with influential figures in the healthcare industry.

Recent Developments:

In October 2023, as per Takeda's announcement, the Phase 3 ADMIRE-CD II research, which evaluated the safety and effectiveness of Alofisel(R) (darvadstrocel) in treating complex Crohn's Perianal Fistulas (CPF), failed to achieve its primary goal of combined remission at 24 weeks, according to topline results. Nothing new was found in terms of safety signals, and darvadstrocel's safety profile matched that of earlier research.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL Adipose Derived Stem Cell MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AlloCure

Antria

Celgene Corporation

Cellleris

Corestem

Cytori Therapeutics

Intrexon

Mesoblast

Pluristem Therapeutics

Tissue Genesis

BioRestorative Therapies

Celltex Therapeutics Corporation

iXCells Biotechnologies

Cyagen

Lonza

Others

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1.Adipose Derived Stem CellMarket Overview

2.Executive Summary

3.Adipose Derived Stem CellKey Market Trends

4.Adipose Derived Stem CellIndustry Study

5.Adipose Derived Stem CellMarket: COVID-19 Impact Analysis

6.Adipose Derived Stem CellMarket Landscape

7.Adipose Derived Stem CellMarket - By Type

8.Adipose Derived Stem CellMarket - By Product Type

9.Adipose Derived Stem CellMarket - By Disease

10.Adipose Derived Stem CellMarket - By End-User

11.Adipose Derived Stem CellMarket- By Geography

12.Key Vendor Analysis- Adipose Derived Stem CellIndustry

13.360 Degree Analyst View

14.Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â